How Fear of Unnecessary Hospital Tests is Impacting the Patient-Provider Relationship

Patients are spending more and more on healthcare, but is it for the right tests and diagnostics? CMS reported that in 2017, individuals paid upwards of $10,000 on average on healthcare expenses alone, yet more than $200 billion is wasted on unnecessary health care tests. The fears surrounding high healthcare costs and unnecessary tests among Americans are a real concern.

The HeartFlow consumer survey found that 42 percent of respondents know that they have a family history of heart disease and another 77 percent admit to worrying about their heart health, yet most (67 percent) have never sought diagnosis or treatment. So, how can we address this issue?

Creating greater awareness of innovations in healthcare as well as fostering rich patient-provider conversations can help. Adoption of everything from artificial intelligence powered technology to wearable devices can help reduce the overall costs to the healthcare system and provide more informed insights to both patients and physicians.

Beyond adoption of technology, here are ways to ease concerns through a more informed patient-driven dialogue:

  1. Ask for Test Options to be Explained Clearly and Concisely – Physicians can outline exactly what test options are available to address the issue at hand. That guidance should highlight how the test is conducted, what could be found and the physician’s recommendation on the best option.
  2. Request the Costs for Tests – A recent poll found that 40 percent of Americans cite paying for healthcare as more frightening than the illness itself. It’s important to take the extra time to understand what’s covered and what’s not with tests. Your physician or the hospital’s administrators should outline the cost of each test so that you can prepare accordingly.
  3. Request Additional Resources – Physicians can point to trusted medical journals or non-profit health organizations for additional insight into test options that can be reviewed at home.

When combining advanced technologies and guided conversations, better trust between a patient and physician can result. In the short term, patients get a better experience, and in the long term, the hope is to help improve outcomes.

To learn more about The HeartFlow Analysis, click here. See a preview of what a 3D HeartFlow Analysis can look like on mobile here (for iOS only) or on desktop here.

Back to Matters of the Heart

Contact Us

*Required fields

Request the HeartFlow Analysis Near You

If you would like to request to have the HeartFlow Analysis available at a location near you, please submit your information below with details of the institution. We will share this information with the institution, but it will not guarantee HeartFlow will become available.

*Required fields

残念ながら、GDPR 規制により、この Web フォームを通じて求人への応募やキャリアに関する問い合わせを受け付けることはできません。弊社を通じてお申込みください 採用ページ. ご関心をお寄せいただきありがとうございます!


HeartFlow FFRCT 分析は、有資格の臨床医による臨床的に安定した症状のある冠状動脈疾患患者への使用を目的とした個別化された心臓検査です。 HeartFlow Analysis によって提供される情報は、資格のある臨床医が患者の病歴、症状、その他の診断検査、および臨床医の専門的判断と組み合わせて使用​​することを目的としています。


さらに質問がある場合は、このメッセージを閉じてフォームに記入するか、サポート チームにお電話ください。: 877.478.3569.

The HeartFlow FFRCT Analysis is a personalized cardiac test indicated for use in clinically stable symptomatic patients with coronary artery disease by qualified clinicians. The information provided by the HeartFlow Analysis is intended to be used by qualified clinicians in conjunction with the patient’s history, symptoms, and other diagnostic tests, as well as the clinician’s professional judgement.

For additional indication information about the HeartFlow Analysis, please visit

If you have additional questions, close out of this message to complete our form or call our support team: 877.478.3569.

Please apply for research grants through our online submission form.

Unfortunately, we cannot take job applications or career inquiries through this web form due to GDPR regulations. Please apply through our Careers Page. Thank you for your interest!

Campbell Rogers, M.D., F.A.C.C.

Executive Vice President and Chief Medical Officer

Campbell brings a wealth of experience to HeartFlow, where he serves as the Chief Medical Officer. Prior to joining HeartFlow, he was the Chief Scientific Officer and Global Head of Research and Development at Cordis Corporation, Johnson & Johnson, where he was responsible for leading investments and research in cardiovascular devices. Prior to Cordis, he was Associate Professor of Medicine at Harvard Medical School and the Harvard-M.I.T. Division of Health Sciences and Technology, and Director of the Cardiac Catheterization and Experimental Cardiovascular Interventional Laboratories at Brigham and Women’s Hospital. He served as Principal Investigator for numerous interventional cardiology device, diagnostic, and pharmacology trials, is the author of numerous journal articles, chapters, and books in the area of coronary artery and other cardiovascular diseases, and was the recipient of research grant awards from the NIH and AHA.

He received his A.B. from Harvard College and his M.D. from Harvard Medical School.